Unique functional roles for class I and class II histone deacetylases in central nervous system development and function

Michael J. Morris, Lisa M Monteggia

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Non-specific pharmacological inhibition of the histone deacetylase (HDAC) family of enzymes has largely beneficial effects in a variety of diverse contexts including cancer, cognitive function, and neurodegeneration. This review will discuss the role of individual HDAC isoforms in brain function during development and in the adult. Importantly class I and class II HDACs exhibit distinct cellular and subcellular expression patterns and utilize different signaling pathways to influence their substrates. Moreover, dissociable phenotypic outcomes emerge following manipulation of individual HDACs in the brain. To date, pharmacological inhibitors capable of targeting individual HDACs have proven difficult to develop, an obstacle that must be overcome to unlock the substantial clinical promise of manipulating endogenous HDAC isoforms in the central nervous system.

Original languageEnglish (US)
Pages (from-to)370-381
Number of pages12
JournalInternational Journal of Developmental Neuroscience
Volume31
Issue number6
DOIs
StatePublished - Oct 2013

Fingerprint

Histone Deacetylases
Central Nervous System
Protein Isoforms
Pharmacology
Brain
Cognition
Enzymes
Neoplasms

Keywords

  • Epigenetic
  • HDAC
  • Learning
  • LTP
  • Synaptic function

ASJC Scopus subject areas

  • Developmental Biology
  • Developmental Neuroscience

Cite this

@article{e2d2307d034a41b7b08f7e71a10fb686,
title = "Unique functional roles for class I and class II histone deacetylases in central nervous system development and function",
abstract = "Non-specific pharmacological inhibition of the histone deacetylase (HDAC) family of enzymes has largely beneficial effects in a variety of diverse contexts including cancer, cognitive function, and neurodegeneration. This review will discuss the role of individual HDAC isoforms in brain function during development and in the adult. Importantly class I and class II HDACs exhibit distinct cellular and subcellular expression patterns and utilize different signaling pathways to influence their substrates. Moreover, dissociable phenotypic outcomes emerge following manipulation of individual HDACs in the brain. To date, pharmacological inhibitors capable of targeting individual HDACs have proven difficult to develop, an obstacle that must be overcome to unlock the substantial clinical promise of manipulating endogenous HDAC isoforms in the central nervous system.",
keywords = "Epigenetic, HDAC, Learning, LTP, Synaptic function",
author = "Morris, {Michael J.} and Monteggia, {Lisa M}",
year = "2013",
month = "10",
doi = "10.1016/j.ijdevneu.2013.02.005",
language = "English (US)",
volume = "31",
pages = "370--381",
journal = "International Journal of Developmental Neuroscience",
issn = "0736-5748",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Unique functional roles for class I and class II histone deacetylases in central nervous system development and function

AU - Morris, Michael J.

AU - Monteggia, Lisa M

PY - 2013/10

Y1 - 2013/10

N2 - Non-specific pharmacological inhibition of the histone deacetylase (HDAC) family of enzymes has largely beneficial effects in a variety of diverse contexts including cancer, cognitive function, and neurodegeneration. This review will discuss the role of individual HDAC isoforms in brain function during development and in the adult. Importantly class I and class II HDACs exhibit distinct cellular and subcellular expression patterns and utilize different signaling pathways to influence their substrates. Moreover, dissociable phenotypic outcomes emerge following manipulation of individual HDACs in the brain. To date, pharmacological inhibitors capable of targeting individual HDACs have proven difficult to develop, an obstacle that must be overcome to unlock the substantial clinical promise of manipulating endogenous HDAC isoforms in the central nervous system.

AB - Non-specific pharmacological inhibition of the histone deacetylase (HDAC) family of enzymes has largely beneficial effects in a variety of diverse contexts including cancer, cognitive function, and neurodegeneration. This review will discuss the role of individual HDAC isoforms in brain function during development and in the adult. Importantly class I and class II HDACs exhibit distinct cellular and subcellular expression patterns and utilize different signaling pathways to influence their substrates. Moreover, dissociable phenotypic outcomes emerge following manipulation of individual HDACs in the brain. To date, pharmacological inhibitors capable of targeting individual HDACs have proven difficult to develop, an obstacle that must be overcome to unlock the substantial clinical promise of manipulating endogenous HDAC isoforms in the central nervous system.

KW - Epigenetic

KW - HDAC

KW - Learning

KW - LTP

KW - Synaptic function

UR - http://www.scopus.com/inward/record.url?scp=84880046571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880046571&partnerID=8YFLogxK

U2 - 10.1016/j.ijdevneu.2013.02.005

DO - 10.1016/j.ijdevneu.2013.02.005

M3 - Article

VL - 31

SP - 370

EP - 381

JO - International Journal of Developmental Neuroscience

JF - International Journal of Developmental Neuroscience

SN - 0736-5748

IS - 6

ER -